Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epstein-Barr Virus Antigen-Expressing Cell (EBV Antigen-Expressing Cell)
- Target
- EBV Antigen-Expressing Cell
- Molecular classification
- Cell, Virus-infected cell, B lymphocyte, Epithelial cell
01
Overview
An Epstein-Barr virus (EBV) antigen-expressing cell is any cell that expresses one or more antigens derived from the Epstein-Barr virus. These cells, primarily B lymphocytes and epithelial cells, are critical in the pathogenesis of EBV-associated diseases and represent targets for therapeutic intervention. The specific antigens expressed depend on the phase of infection (lytic or latent) and the latency program active in the infected cell. Key viral antigens include EBNAs (especially EBNA1 and EBNA2), LMPs, and tegument protein BNRF1. Targeting these cells aims to reduce viral load, control EBV-associated malignancies, and modulate the immune response to prevent disease progression.
- Other names
- EBV-infected cellEBV positive cellCell expressing EBV antigens
02
Mechanism of action
Drugs can target viral replication, EBV-infected cells, or modulate the immune response against EBV-expressing cells.
03
Biological functions
Viral replicationAntigen presentationImmune stimulationTumorigenesisViral latencyB cell transformation
04
Disease associations
Infectious mononucleosisBurkitt lymphomaHodgkin lymphomaNasopharyngeal carcinomaPost-transplant lymphoproliferative disorder (PTLD)Other EBV-associated malignancies
05
Safety considerations
Drug resistanceImmunosuppressionOff-target effectsDevelopment of secondary malignancies
06
Interacting drugs
Acyclovir
4 more in the full profile.
07
Biomarkers
EBV DNA loadExpression levels of specific EBV antigens (e.g., EBNA1, LMP1)Presence of EBV-encoded small RNAs (EBERs)Immune cell populations (e.g., CD8+ T cell count)MHC class I expressionAntibody titers against EBV antigens
Beyond the preview
Go deeper on Epstein-Barr Virus Antigen-Expressing Cell (EBV Antigen-Expressing Cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epstein-Barr Virus Antigen-Expressing Cell (EBV Antigen-Expressing Cell).